Diagnostics Surgical Supply ApS
CVR number: 34472122
Evertvej 28, 4040 Jyllinge
ljj@dss-eu.com
tel: 70260048
www.dss-eu.com
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 1 165.28 | 1 393.75 | 1 698.60 | 3 949.38 | -48.20 |
Employee benefit expenses | -1 080.26 | - 701.89 | -1 190.46 | -1 246.30 | - 574.46 |
Total depreciation | -8.34 | -6.93 | -16.88 | -18.09 | |
EBIT | 76.68 | 684.93 | 508.14 | 2 686.20 | - 640.75 |
Other financial income | 6.08 | 4.62 | 31.62 | 25.99 | 383.29 |
Other financial expenses | -49.54 | -91.71 | -30.97 | -61.23 | - 271.59 |
Reduction non-current investment assets | -65.22 | -1.02 | -10.69 | ||
Pre-tax profit | -32.00 | 596.82 | 498.10 | 2 650.96 | - 529.05 |
Income taxes | 3.90 | - 147.02 | - 113.92 | - 583.04 | 60.61 |
Net earnings | -28.10 | 449.80 | 384.19 | 2 067.92 | - 468.44 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible assets total | |||||
Machinery and equipment | 6.93 | 73.58 | 55.48 | ||
Tangible assets total | 6.93 | 73.58 | 55.48 | ||
Holdings in group member companies | 52.35 | 51.33 | |||
Investments total | 52.35 | 51.33 | |||
Non-current other receivables | 26.81 | 26.01 | 26.01 | 6.50 | |
Long term receivables total | 26.81 | 26.01 | 26.01 | 6.50 | |
Finished products/goods | 761.66 | 951.35 | 871.57 | 350.84 | 196.62 |
Inventories total | 761.66 | 951.35 | 871.57 | 350.84 | 196.62 |
Current trade debtors | 927.00 | 605.90 | 690.29 | 567.07 | 40.62 |
Prepayments and accrued income | 16.81 | 17.14 | 23.61 | ||
Current other receivables | 6.00 | 3.35 | |||
Current deferred tax assets | 63.70 | 5.17 | 68.48 | ||
Short term receivables total | 1 013.52 | 628.21 | 713.90 | 570.43 | 109.10 |
Other current investments | 1 883.58 | ||||
Cash and bank deposits | 1 150.80 | 1 721.81 | 3 025.33 | 43.02 | |
Cash and cash equivalents | 1 150.80 | 1 721.81 | 3 025.33 | 1 926.60 | |
Balance sheet total (assets) | 1 861.27 | 2 807.70 | 3 333.30 | 4 026.67 | 2 287.81 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
Shares repurchased | 113.00 | 114.60 | 117.80 | ||
Retained earnings | - 144.83 | - 172.93 | 163.87 | 433.46 | 2 383.58 |
Profit of the financial year | -28.10 | 449.80 | 384.19 | 2 067.92 | - 468.44 |
Shareholders equity total | -92.93 | 356.87 | 741.06 | 2 695.98 | 2 112.93 |
Provisions | 5.25 | ||||
Non-current other liabilities | 2.85 | 31.84 | |||
Non-current deferred tax liabilities | 85.48 | 109.75 | 570.79 | ||
Non-current liabilities total | 2.85 | 117.33 | 109.75 | 570.79 | |
Current loans from credit institutions | 434.86 | ||||
Advances received | 21.87 | ||||
Current trade creditors | 545.56 | 543.67 | 411.70 | 118.77 | 78.35 |
Short-term deferred tax liabilities | 88.20 | 0.16 | 0.52 | ||
Other non-interest bearing current liabilities | 973.78 | 1 789.83 | 1 982.59 | 635.73 | 74.14 |
Current liabilities total | 1 954.19 | 2 333.50 | 2 482.49 | 754.66 | 174.88 |
Balance sheet total (liabilities) | 1 864.12 | 2 807.70 | 3 333.30 | 4 026.67 | 2 287.81 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.